Concepedia
Statistics
Publications
10
Citations
513
H-Index
Active since
2001
Affiliations
University of Wisconsin–Madison(Current)
University of Arizona
ioGenetics (United States)
Scripps Research Institute
Michael Imboden is an author at University of Wisconsin–Madison specializing in immunology, cancer immunology, and oncology.
Publications per year
2001–2020
Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells
Joel G. Turner, Alexander L. Rakhmilevich, Lyudmila G. Burdelya et al. · The Journal of Immunology · 2001 · 104 citations · Full text
Life Sciences, Immunology, Oncology +13
Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy
Zane C. Neal, Jeannie C. Yang, Alexander L. Rakhmilevich et al. · Clinical Cancer Research · 2004 · 94 citations
Life Sciences, Immunology, Oncology +16
Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa
Sujun Li, Shyamtanu Datta, Emily Brabbit et al. · Gene Therapy · 2020 · 63 citations · Full text
Medicine, Genetics, Molecular Biology +17
Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor.
Alexander L. Rakhmilevich, Michael Imboden, Zhengling Hao et al. · PubMed · 2001 · 51 citations
Pharmacy, Immunology, Oncology +17
NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy
Zane C. Neal, Michael Imboden, Alexander L. Rakhmilevich et al. · Cancer Immunology Immunotherapy · 2003 · 49 citations · Full text
Life Sciences, Immunology, Oncology +15
1–5 of 10